176 related articles for article (PubMed ID: 19275869)
1. Prediction of the oversulphated chondroitin sulphate contamination of unfractionated heparin by ATR-IR spectrophotometry.
Norwig J; Beyer T; Brinz D; Holzgrabe U; Diller M; Manns D
Pharmeur Sci Notes; 2009 Mar; 2009(1):17-24. PubMed ID: 19275869
[TBL] [Abstract][Full Text] [Related]
2. Combining (1)H NMR spectroscopy and chemometrics to identify heparin samples that may possess dermatan sulfate (DS) impurities or oversulfated chondroitin sulfate (OSCS) contaminants.
Zang Q; Keire DA; Wood RD; Buhse LF; Moore CM; Nasr M; Al-Hakim A; Trehy ML; Welsh WJ
J Pharm Biomed Anal; 2011 Apr; 54(5):1020-9. PubMed ID: 21215547
[TBL] [Abstract][Full Text] [Related]
3. Determination of oversulfated chondroitin sulfate and dermatan sulfate impurities in heparin by capillary electrophoresis.
Somsen GW; Tak YH; Toraño JS; Jongen PM; de Jong GJ
J Chromatogr A; 2009 May; 1216(18):4107-12. PubMed ID: 19272607
[TBL] [Abstract][Full Text] [Related]
4. Determination of Oversulphated Chondroitin Sulphate and Dermatan Sulphate in unfractionated heparin by (1)H-NMR - Collaborative study for quantification and analytical determination of LoD.
McEwen I; Mulloy B; Hellwig E; Kozerski L; Beyer T; Holzgrabe U; Wanko R; Spieser JM; Rodomonte A
Pharmeuropa Bio; 2008 Dec; 2008(1):31-9. PubMed ID: 19220979
[TBL] [Abstract][Full Text] [Related]
5. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
[TBL] [Abstract][Full Text] [Related]
6. Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency.
McEwen I; Amini A; Olofsson IM
Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):65-72. PubMed ID: 20223191
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.
McEwen I; Rundlöf T; Ek M; Hakkarainen B; Carlin G; Arvidsson T
J Pharm Biomed Anal; 2009 Apr; 49(3):816-9. PubMed ID: 19179033
[TBL] [Abstract][Full Text] [Related]
8. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
[TBL] [Abstract][Full Text] [Related]
9. Analysis of heparin sodium by SAX/HPLC for contaminants and impurities.
Trehy ML; Reepmeyer JC; Kolinski RE; Westenberger BJ; Buhse LF
J Pharm Biomed Anal; 2009 Apr; 49(3):670-3. PubMed ID: 19167854
[TBL] [Abstract][Full Text] [Related]
10. An assessment of polydispersed species in unfractionated and low molecular weight heparins by diffusion ordered nuclear magnetic resonance spectroscopy method.
Bednarek E; Sitkowski J; Bocian W; Mulloy B; Kozerski L
J Pharm Biomed Anal; 2010 Nov; 53(3):302-8. PubMed ID: 20417048
[TBL] [Abstract][Full Text] [Related]
11. Broadening of 1H NMR signals in the spectra of heparin and OSCS by paramagnetic transition metal ions. The use of EDTA to sharpen the signals.
McEwen I
J Pharm Biomed Anal; 2010 Feb; 51(3):733-5. PubMed ID: 19782493
[TBL] [Abstract][Full Text] [Related]
12. Improved impurity fingerprinting of heparin by high resolution (1)H NMR spectroscopy.
Bigler P; Brenneisen R
J Pharm Biomed Anal; 2009 May; 49(4):1060-4. PubMed ID: 19211212
[TBL] [Abstract][Full Text] [Related]
13. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
Bairstow S; McKee J; Nordhaus M; Johnson R
Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
[TBL] [Abstract][Full Text] [Related]
14. Quality assessment of unfractionated heparin using 1H nuclear magnetic resonance spectroscopy.
Beyer T; Diehl B; Randel G; Humpfer E; Schäfer H; Spraul M; Schollmayer C; Holzgrabe U
J Pharm Biomed Anal; 2008 Sep; 48(1):13-9. PubMed ID: 18678460
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
[TBL] [Abstract][Full Text] [Related]
16. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
[TBL] [Abstract][Full Text] [Related]
17. Determination of impurities in heparin by capillary electrophoresis using high molarity phosphate buffers.
Wielgos T; Havel K; Ivanova N; Weinberger R
J Pharm Biomed Anal; 2009 Feb; 49(2):319-26. PubMed ID: 19155153
[TBL] [Abstract][Full Text] [Related]
18. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
Volpi N; Maccari F; Linhardt RJ
Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
[TBL] [Abstract][Full Text] [Related]
19. Nuclear magnetic resonance spectra of heparin in admixture with dermatan sulfate and other glycosaminoglycans. 2-D spectra of the chondroitin sulfates.
Holme KR; Perlin AS
Carbohydr Res; 1989 Mar; 186(2):301-12. PubMed ID: 2500236
[TBL] [Abstract][Full Text] [Related]
20. Determination of dermatan sulfate and chondroitin sulfate as related substances in heparin by capillary electrophoresis.
Bendazzoli C; Liverani L; Spelta F; Prandi M; Fiori J; Gotti R
J Pharm Biomed Anal; 2010 Dec; 53(5):1193-200. PubMed ID: 20674212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]